RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Revolution Medicines Stock

Revolution Medicines Equity 2025

Revolution Medicines Equity

2.27 B USD

Ticker

RVMD

ISIN

US76155X1000

WKN

A2PYWG

In 2025, Revolution Medicines's equity was 2.27 B USD, a 24.04% increase from the 1.83 B USD equity in the previous year.

Revolution Medicines Aktienanalyse

What does Revolution Medicines do?

Revolution Medicines Inc is a biotechnology company specializing in the development of cancer medications. It was founded in 2014 in Redwood City, California. The company has received significant investment amounts in recent years and is focused on researching and developing personalized cancer therapies that act on a molecular level. They employ a new method called "in-situ imaging" for faster and more precise identification of treatment options. Revolution Medicines is divided into various areas including research and development of new drugs, collaboration with external partners, and conducting their own testing procedures. Their products include a variety of tailored cancer therapies, with RMC-4630 being one of their most promising therapies for advanced breast cancer. They have more products in development and aim to expand their development opportunities through partnerships with other companies in the cancer research field. This company aims to revolutionize cancer research by developing targeted therapies customized to meet individual patient needs, utilizing innovative methods and technologies. However, they face challenges in understanding and treating the complexity of molecular processes in cancer cells, as well as competition in the field. Overall, Revolution Medicines is a biotechnology company focused on shaping the future of cancer research. Revolution Medicines ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Revolution Medicines's Equity

Revolution Medicines's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Revolution Medicines's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Revolution Medicines's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Revolution Medicines's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Revolution Medicines’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Revolution Medicines stock

What is the equity of Revolution Medicines this year?

Revolution Medicines has equity of 2.27 B USD this year.

What was the equity of Revolution Medicines compared to the previous year?

The equity of Revolution Medicines has increased/decreased by 24.04% increased compared to the previous year.

What impact does a high equity have on investors of Revolution Medicines?

A high equity is advantageous for investors of Revolution Medicines as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Revolution Medicines?

A low equity can be a risk for investors of Revolution Medicines, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Revolution Medicines affect the company?

An increase in equity of Revolution Medicines can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Revolution Medicines affect the company?

A reduction in equity of Revolution Medicines can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Revolution Medicines?

Some factors that can affect the equity of Revolution Medicines include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Revolution Medicines so important for investors?

The equity of Revolution Medicines is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Revolution Medicines take to change the equity?

To change equity, Revolution Medicines can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Revolution Medicines pay?

Over the past 12 months, Revolution Medicines paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Revolution Medicines is expected to pay a dividend of 0 USD.

What is the dividend yield of Revolution Medicines?

The current dividend yield of Revolution Medicines is .

When does Revolution Medicines pay dividends?

Revolution Medicines pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Revolution Medicines?

Revolution Medicines paid dividends every year for the past 0 years.

What is the dividend of Revolution Medicines?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Revolution Medicines located?

Revolution Medicines is assigned to the 'Health' sector.

Wann musste ich die Aktien von Revolution Medicines kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Revolution Medicines from 10/31/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/31/2025.

When did Revolution Medicines pay the last dividend?

The last dividend was paid out on 10/31/2025.

What was the dividend of Revolution Medicines in the year 2024?

In the year 2024, Revolution Medicines distributed 0 USD as dividends.

In which currency does Revolution Medicines pay out the dividend?

The dividends of Revolution Medicines are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Revolution Medicines

Our stock analysis for Revolution Medicines Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Revolution Medicines Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.